ProFound AI Risk Outperforms Traditional, Widely-Accepted Breast Cancer Risk Models for Both Short-term and Long-term Risk Assessments
04 avr. 2023 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., April 04, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced new...
iCAD Reports Financial Results for Fourth Quarter ended December 31, 2022 and Year End
28 mars 2023 16h01 HE
|
iCAD, Inc.
Strategy focused on profitability by end of 2024, using current cash on hand New leadership to host conference call and webcast today at 4:30 PM ET NASHUA, N.H., March 28, 2023 (GLOBE NEWSWIRE)...
iCAD’s Breast AI Suite Empowers Customers to Lead the Way in Support of FDA’s National Breast Density Reporting Standard
23 mars 2023 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., March 23, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced its...
iCAD Previews Fourth Quarter Financial Results, Full Report on March 28, 2023
13 mars 2023 08h30 HE
|
iCAD, Inc.
NASHUA, N.H., March 13, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
iCAD Announces Leadership Transition
13 mars 2023 08h00 HE
|
iCAD, Inc.
Stacey Stevens Resigns as President and CEO and as a Member of the Board Dana Brown Named President and CEO, remains Chairman of the Board NASHUA, N.H., March 13, 2023 (GLOBE NEWSWIRE) -- iCAD,...
New Real-World Clinical Evidence Confirms ProFound AI Boosts Radiologists’ Efficiency and Accuracy
01 mars 2023 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., March 01, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced new...
iCAD to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
09 févr. 2023 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Feb. 09, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Company...
iCAD Announces CFO Transition and Hires New Senior Vice President, US Commercial Sales, AI
23 janv. 2023 08h00 HE
|
iCAD, Inc.
Daniel Shea appointed as interim Chief Financial Officer William Keyes hired as Senior Vice President, US Commercial Sales, AI NASHUA, N.H., Jan. 23, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:...
iCAD Announces Board of Directors Transition
11 janv. 2023 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Jan. 11, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the...
iCAD features Solis Mammography in upcoming “ProFound Insights, ProFound Impact” webinar
08 déc. 2022 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Dec. 08, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced Solis...